$205.99
-1.40%
N/A-$2.93
Healthcare
Drug Manufacturers - General
NASDAQ
Active Trading
Biogen Inc. is a leading biotechnology firm dedicated to the discovery, development, production, and distribution of treatments for complex neurological and neurodegenerative ...
Financial highlights
Latest / TTM · 6 periods
Snapshot
Latest / TTM: 2026-07-21
Gross Margin
—
Net Margin
—
P/E Ratio
—
Debt / Equity
—
Profitability
Profitability table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Gross MarginGross profit as a percentage of revenue. | 80.8% | 77.6% | 74.2% | 76.1% | 70.5% | — |
| Operating MarginOperating income as a percentage of revenue. | 25.4% | 28.4% | 21.3% | 25.7% | 19.1% | — |
| Net MarginNet income as a percentage of revenue. | 14.2% | 29.9% | 11.8% | 16.9% | 13.2% | — |
| EBITDA MarginEBITDA divided by revenue. | 35.7% | 34.8% | 24.2% | 31.0% | 31.6% | — |
| Pre-tax MarginPre-tax profit as a percentage of revenue. | 16.2% | 35.3% | 13.2% | 19.7% | 14.3% | — |
Liquidity & leverage
Liquidity & leverage table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Current RatioCurrent assets divided by current liabilities. | 1.83 | 2.99 | 2.00 | 1.35 | 2.68 | — |
| Quick RatioLiquid assets divided by current liabilities. | 1.51 | 2.58 | 1.26 | 0.90 | 2.03 | — |
| Cash RatioCash and equivalents divided by current liabilities. | 0.53 | 1.04 | 0.31 | 0.43 | 0.90 | — |
| Debt / AssetsDebt as a share of total assets. | 31.8% | 26.9% | 27.3% | 23.6% | 23.6% | — |
| Debt / EquityDebt compared with shareholder equity. | 0.70 | 0.49 | 0.50 | 0.40 | 0.38 | — |
Operating efficiency
Operating efficiency table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Receivables TurnoverHow often receivables are collected in a year. | 5.60x | 4.76x | 4.68x | 5.18x | 5.25x | — |
| Inventory TurnoverHow often inventory is sold in a year. | 1.56x | 1.69x | 1.00x | 0.94x | 1.34x | — |
| Payables TurnoverHow often payables are paid in a year. | 3.58x | 4.64x | 6.28x | 5.45x | 6.71x | — |
| Asset TurnoverRevenue generated per dollar of assets. | 0.46x | 0.41x | 0.37x | 0.34x | 0.33x | — |
| Working Capital TurnoverRevenue generated per dollar of working capital. | 3.28x | 2.02x | 1.98x | 3.62x | 2.60x | — |
Valuation ratios
Valuation ratios table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| P/E RatioPrice paid for each dollar of earnings. | 22.98x | 13.21x | 32.27x | 13.65x | 19.89x | — |
| P/B RatioPrice paid for each dollar of book value. | 3.28x | 3.00x | 2.53x | 1.33x | 1.41x | — |
| P/S RatioPrice paid for each dollar of sales. | 3.26x | 3.96x | 3.81x | 2.30x | 2.63x | — |
| P/FCF RatioPrice paid for each dollar of free cash flow. | 10.58x | 35.17x | 30.30x | 8.86x | 12.59x | — |
| Dividend YieldAnnual dividend divided by current share price. | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |